IN-ARMOR PROJECT

IN-ARMOR PROJECT is at the forefront of biotechnology research, dedicated to developing innovative solutions for combating antimicrobial resistance. With a focus on therapeutic epigenetic enhancement of innate immunity, IN-ARMOR PROJECT aims to introduce a novel class of immune system inducers, enhancing the body’s natural defenses against microbial threats. This initiative is focused on reducing the incidence of the 13 most dangerous infections.

Leveraging advanced technologies, IN-ARMOR PROJECT optimizes an already developed drug platform through Computer Aided Drug Design and in-silico approaches, paired with a nanotech-based drug delivery system. The developed therapy undergoes rigorous pre-clinical validation for safety and efficacy, ensuring it meets all Investigational Medicinal Product requirements. IN-ARMOR PROJECT is dedicated to preparing for clinical validation, marking a significant step towards commercialization.

IN-ARMOR PROJECT's efforts have the potential to save millions of lives worldwide and significantly reduce the burden of antibiotic development. The long-term impact includes substantial cost reduction and a decrease in the global disease burden. To the management of IN-ARMOR PROJECT: We invite you to create a customized and exclusive company showcase and product listing on our platform to further amplify your reach and impact.